By conjugating the QDs with antibodies targeting specific tumor features, they were able to monitor T-cell dynamics in the tumor microcirculation and to detect programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) in tumors with cellular resolution. The gene discussed is CD274; the disease is neoplasm.